PBH
Prestige Consumer Healthcare Inc.
Key Financials
Net Income
$214.6M
↑ 2.5%
Operating Income
$336.8M
↓ 1.7%
Revenue
$1.1B
↑ 1.1%
Gross Profit
$634.5M
↑ 1.6%
EPS (Diluted)
$4.29
↑ 2.9%
Cash & Equivalents
$97.9M
↑ 110.6%
Total Liabilities
$1.6B
↓ 5.8%
Shareholders' Equity
$1.8B
↑ 10.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/13/2026 | View on SEC |
| 144 | 2/11/2026 | View on SEC |
| 10-Q | 2/5/2026 | View on SEC |
| 8-K | 2/5/2026 | View on SEC |
| 4 | 1/29/2026 | View on SEC |
| 3 | 1/29/2026 | View on SEC |
| 4 | 12/2/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PBH |
| Company Name | Prestige Consumer Healthcare Inc. |
| CIK | 1295947 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| Phone | (914) 524-6800 |